Linezolid resistance genes and genetic elements enhancing their dissemination in enterococci and streptococci

Plasmid. 2018 Sep:99:89-98. doi: 10.1016/j.plasmid.2018.09.011. Epub 2018 Sep 22.

Abstract

Linezolid is considered a last resort drug in treatment of severe infections caused by Gram-positive pathogens, resistant to other antibiotics, such as vancomycin-resistant enterococci (VRE), methicillin-resistant staphylococci and multidrug resistant pneumococci. Although the vast majority of Gram-positive pathogenic bacteria remain susceptible to linezolid, resistant isolates of enterococci, staphylococci and streptococci have been reported worldwide. In these bacteria, apart from mutations, affecting mostly the 23S rRNA genes, acquisition of such genes as cfr, cfr(B), optrA and poxtA, often associated with mobile genetic elements (MGE), plays an important role for resistance. The purpose of this paper is to provide an overview on diversity and epidemiology of MGE carrying linezolid-resistance genes among clinically-relevant Gram-positive pathogens such as enterococci and streptococci.

Keywords: Alert pathogens; Hospital infections; cfr; optrA; rep.

Publication types

  • Review

MeSH terms

  • Drug Resistance, Bacterial / genetics*
  • Drug Resistance, Multiple, Bacterial / genetics
  • Enterococcus / drug effects
  • Enterococcus / genetics*
  • Enterococcus / pathogenicity
  • Humans
  • Linezolid / therapeutic use
  • Plasmids / genetics*
  • RNA, Ribosomal, 23S / genetics
  • Streptococcus / drug effects
  • Streptococcus / genetics*
  • Streptococcus / pathogenicity

Substances

  • RNA, Ribosomal, 23S
  • Linezolid